Head-To-Head Analysis: Alignment Healthcare (NASDAQ:ALHC) and INVO Fertility (NASDAQ:IVF)

Alignment Healthcare (NASDAQ:ALHC) and INVO Fertility (NASDAQ:IVF) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

Insider & Institutional Ownership

86.2% of Alignment Healthcare shares are owned by institutional investors. Comparatively, 12.0% of INVO Fertility shares are owned by institutional investors. 5.2% of Alignment Healthcare shares are owned by company insiders. Comparatively, 0.4% of INVO Fertility shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Volatility & Risk

Alignment Healthcare has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500. Comparatively, INVO Fertility has a beta of 2.34, meaning that its stock price is 134% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and target prices for Alignment Healthcare and INVO Fertility, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alignment Healthcare	0	4	7	0	2.64
INVO Fertility	1	0	0	1	2.50

Alignment Healthcare presently has a consensus price target of $23.60, suggesting a potential upside of 84.95%. INVO Fertility has a consensus price target of $20.00, suggesting a potential upside of 1,974.69%. Given INVO Fertility’s higher possible upside, analysts clearly believe INVO Fertility is more favorable than Alignment Healthcare.

Valuation & Earnings

This table compares Alignment Healthcare and INVO Fertility”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alignment Healthcare	$3.95 billion	0.67	-$720,000.00	$0.19	67.16
INVO Fertility	$6.84 million	0.35	-$25.13 million	($33.83)	-0.03

Alignment Healthcare has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Alignment Healthcare and INVO Fertility’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alignment Healthcare	0.89%	20.02%	3.46%
INVO Fertility	-116.29%	-85.54%	-31.05%

Summary

Alignment Healthcare beats INVO Fertility on 12 of the 15 factors compared between the two stocks.

About Alignment Healthcare

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

About INVO Fertility

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.